Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Microbio Co's ROE % for the quarter that ended in Dec. 2025 was -1.62%. Microbio Co's PB Ratio for the quarter that ended in Dec. 2025 was 1.22.
Microbio Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -1.33%.
Microbio Co ROE % Adjusted to Book Value Related Terms
Microbio Co ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Microbio Co's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4128 vs KHC, GIS: ROE % Adjusted to Book Value Comparison
For the Packaged Foods subindustry, Microbio Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Microbio Co ROE % Adjusted to Book Value vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Microbio Co's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Microbio Co's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -1.33% mean?
Microbio Co (ROCO:4128) has a ROE % Adjusted to Book Value of -1.33% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Microbio Co and its competitors.
Is Microbio Co's ROE % Adjusted to Book Value too high?
Microbio Co's current ROE % Adjusted to Book Value is -1.33%. Overall, Microbio Co has a GF Score™ of 56/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Microbio Co's ROE % Adjusted to Book Value compare to KHC and GIS?
Microbio Co's ROE % Adjusted to Book Value of -1.33% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Consumer Packaged Goods company?
A good ROE % Adjusted to Book Value depends on the Consumer Packaged Goods industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Microbio Co and its competitors. Microbio Co's current ROE % Adjusted to Book Value is -1.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Microbio Co stock overvalued right now?
Based on GuruFocus' analysis, Microbio Co (ROCO:4128) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$45.77, compared to a current price of NT$15.85 — trading 65.4% below its estimated fair value. The current ROE % Adjusted to Book Value is -1.33%. Microbio Co's overall GF Score™ is 56/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Microbio Co (ROCO:4128), the current ROE % Adjusted to Book Value is -1.33% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Microbio Co (ROCO:4128) Overvalued in 2026?
Based on GuruFocus' analysis, Microbio Co stock appears to be undervalued.
The current stock price of NT$15.85 is trading 65.4% below its estimated GF Value™ of NT$45.77.
GuruFocus considers Microbio Co to be Significantly Undervalued.
Key valuation signals for ROCO:4128:
ROE % Adjusted to Book Value: -1.33%
GF Value™: NT$45.77 vs. price of NT$15.85 (65.4% below fair value)
No single metric tells the full story. See the ROCO:4128 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development and the sale of dietary supplements. The majority of its revenue is generated from the sale of its dietary supplements.
56GF Score
Get the complete analysis for ROCO:4128
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4128 has been successfully added to your 
